$1.41
-0.10-6.62%
At close: -
$1.60
0.1913.48%
After Hours: Feb 19, 8:14 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for XTL Biopharmaceuticals in recent months.
Browse guidance and forecast on all stocks.